ArticleHaematologica2024

Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximab.

Marie Emilie Dourthe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.